Following the comment period Department staff shall review all evidence and commentary concerning the proposed amendments, and shall report its recommendation to the Commission. The Commission shall consider the staff recommendations, make such revisions as it deems appropriate, and shall recommend Amendments to the List of Interchangeable Drug Products for adoption by the Commissioner and the Public Health Council.
105 CMR, § 720.084